Outcomes

What were the main findings from the study?

• MICARDIS^® significantly decreased the potential of patients developing overt nephropathy, even in patients who were normotensive.⁸
• MICARDIS^® was superior to placebo in achieving microalbuminuria remission, an important outcome in patients at high risk of ESRD.⁸
• The preventative effects of MICARDIS^® on the transition to diabetic nephropathy and protection against the development of macroalbuminuria may be independent of its blood-pressure lowering effects.⁸

References